Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$2.31 - $5.13 $45,058 - $100,065
-19,506 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$4.45 - $8.09 $1,628 - $2,960
-366 Reduced 1.84%
19,506 $93,000
Q3 2021

Nov 12, 2021

BUY
$6.94 - $8.85 $49,787 - $63,489
7,174 Added 56.5%
19,872 $156,000
Q1 2021

May 12, 2021

BUY
$8.78 - $12.8 $111,488 - $162,534
12,698 New
12,698 $143,000

About CURIS INC


  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $409M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track E Fund Management Co., Ltd. Portfolio

Follow E Fund Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.